Home india India Equity: Bharat_Immunolog (#524663) declares Quarterly Results. EPS = Rs -2.17 for quarter ended Sep 2021

India Equity: Bharat_Immunolog (#524663) declares Quarterly Results. EPS = Rs -2.17 for quarter ended Sep 2021

0
India Equity: Bharat_Immunolog (#524663) declares Quarterly Results. EPS = Rs -2.17 for quarter ended Sep 2021

Join the India Equity Telegram Group for analysis, updates and results

524663 has declared results for the period ended Sep 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • Sales for period ended Sep 2021 is Rs 24.7 cr compared to Rs 25.36 cr for period ended Sep 2020, a fall of 2.6%
  • Company reported negative operating profit of Rs -3.49 cr for period ended Sep 2021. For same period last year, operating profit was -4.5
  • The EPS for Sep 2021 was Rs -2.17 compared to Rs 0.45 for previous quarter ended Jun 2021 and Rs -0.9 for Sep 2020
  • The stock is trading at Rs 54.10 and a market cap of Rs 234 cr

[/s2If]

Trading Chart


Further analysis and Full Company Research with investing scores is available here: 524663

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter